News
Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford ...
16d
Clinical Trials Arena on MSNBio-Thera Solutions doses first subject in Phase III ADC ovarian cancer trialBio-Thera Solutions has initiated dosing in the randomised Phase III trial of the antibody-drug conjugate (ADC), BAT8006, ...
Vietnam Investment Review on MSN8d
Akeso's First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in 'IO+ADC' 2.0 StrategyAkeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) ...
Conjugation is the process by which one bacterium transfers genetic material to another through direct contact. During conjugation, one bacterium serves as the donor of the genetic material, and ...
IO Interactive finally showed off its take on James Bond with a new trailer for 007 First Light at Sony's State of Play.
Compared to the unmodified aptamer-drug conjugate, the modified aptamer-drug conjugate exhibited significantly improved binding and endocytosis ability towards targeted pancreatic cancer cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results